|
Yang, Jun; Mager, Donald E; Straubinger, Robert M (2010) Comparison of two pharmacodynamic transduction models for the analysis of tumor therapeutic responses in model systems. AAPS J 12:1-10
|
|
Zhou, Rong; Mazurchuk, Richard V; Tamburlin, Judith H et al. (2010) Differential pharmacodynamic effects of paclitaxel formulations in an intracranial rat brain tumor model. J Pharmacol Exp Ther 332:479-88
|
|
Straubinger, Robert M; Krzyzanski, Wojciech; Francoforte, Crystal M et al. (2007) Applications of quantitative pharmacodynamic effect markers in drug target identification and therapy development. Anticancer Res 27:1237-46
|
|
Straubinger, Robert M; Arnold, Robert D; Zhou, Rong et al. (2004) Antivascular and antitumor activities of liposome-associated drugs. Anticancer Res 24:397-404
|
|
Fetterly, Gerald J; Straubinger, Robert M (2003) Pharmacokinetics of paclitaxel-containing liposomes in rats. AAPS PharmSci 5:E32
|
|
Fetterly, G J; Tamburlin, J M; Straubinger, R M (2001) Paclitaxel pharmacodynamics: application of a mechanism-based neutropenia model. Biopharm Drug Dispos 22:251-61
|
|
Campbell, R B; Balasubramanian, S V; Straubinger, R M (2001) Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes. J Pharm Sci 90:1091-105
|
|
Campbell, R B; Balasubramanian, S V; Straubinger, R M (2001) Phospholipid-cationic lipid interactions: influences on membrane and vesicle properties. Biochim Biophys Acta 1512:27-39
|
|
Zhou, R; Balasubramanian, S V; Kahl, S B et al. (1999) Biopharmaceutics of boronated radiosensitizers: liposomal formulation of MnBOPP (manganese chelate of 2,4-(alpha, beta-dihydroxyethyl) deuterioporphyrin IX) and comparative toxicity in mice. J Pharm Sci 88:912-7
|
|
Mazurchuk, R; Zhou, R; Straubinger, R M et al. (1999) Functional magnetic resonance (fMR) imaging of a rat brain tumor model: implications for evaluation of tumor microvasculature and therapeutic response. Magn Reson Imaging 17:537-48
|
Showing the most recent 10 out of 18 publications
